Nucleic Acid Amplification Testing Market Size, Share & Trends Analysis Report By Type (PCR, INAAT), By Application (Infectious Disease Testing, Oncology Testing), By End-use, By Region, And Segment Forecasts, 2018 - 2030
This report can be delivered to the clients within 3 Business Days
Nucleic Acid Amplification Testing Market Growth & Trends
The global nucleic acid amplification testing market is expected to reach USD 19.23 billion by 2030, registering a CAGR of 12.78% during the forecast period, according to a new report by Grand View Research, Inc. Rising awareness regarding early detection of chronic and infectious diseases, and emerging technological advancements in PCR technology are the factors expected to significantly drive the market growth. In addition, the global rise in the prevalence of infectious diseases such as influenza, hepatitis, and sexually transmitted infections is anticipated to increase the demand for nucleic acid amplification testing and positively affect market growth.
Nucleic acid amplification testing has witnessed a high amount of investment in recent years due to its applicability to diagnose a variety of disease conditions, including life-threatening conditions such as cancer. For instance, the development of Cepheid’s Gene Xpert technology involved a total public investment of over USD 252.0 million, including grants of more than USD 56.0 million from the National Institutes of Health, and around USD 73.0 million from other U.S. government departments.
Moreover, the high efficiency and accuracy of nucleic acid amplification testing have led to an increasing preference for the technique over traditional diagnostic options, such as culture-based identification. These attributes are boosting the growth of nucleic acid amplification testing technologies.
COVID-19 has increased demand for rapid and accurate testing methods, including nucleic acid amplification testing, for the detection of the SARS-CoV-2 virus. Key players involved in the market have developed new product offerings, such as isothermal nucleic acid amplification technology-based tests, to meet the high demand for rapid and point-of-care testing.
For instance, in March 2020, Abbott Laboratories received Emergency Use Authorization (EUA) for its Abbott ID NOW COVID-19 test which can deliver positive results within five minutes and negative results within 13 minutes. Such strategic initiatives fueled by the pandemic are expected to boost market growth in the near future.
Nucleic Acid Amplification Testing Market Report Highlights
Nucleic Acid Amplification Testing Market Growth & Trends
The global nucleic acid amplification testing market is expected to reach USD 19.23 billion by 2030, registering a CAGR of 12.78% during the forecast period, according to a new report by Grand View Research, Inc. Rising awareness regarding early detection of chronic and infectious diseases, and emerging technological advancements in PCR technology are the factors expected to significantly drive the market growth. In addition, the global rise in the prevalence of infectious diseases such as influenza, hepatitis, and sexually transmitted infections is anticipated to increase the demand for nucleic acid amplification testing and positively affect market growth.
Nucleic acid amplification testing has witnessed a high amount of investment in recent years due to its applicability to diagnose a variety of disease conditions, including life-threatening conditions such as cancer. For instance, the development of Cepheid’s Gene Xpert technology involved a total public investment of over USD 252.0 million, including grants of more than USD 56.0 million from the National Institutes of Health, and around USD 73.0 million from other U.S. government departments.
Moreover, the high efficiency and accuracy of nucleic acid amplification testing have led to an increasing preference for the technique over traditional diagnostic options, such as culture-based identification. These attributes are boosting the growth of nucleic acid amplification testing technologies.
COVID-19 has increased demand for rapid and accurate testing methods, including nucleic acid amplification testing, for the detection of the SARS-CoV-2 virus. Key players involved in the market have developed new product offerings, such as isothermal nucleic acid amplification technology-based tests, to meet the high demand for rapid and point-of-care testing.
For instance, in March 2020, Abbott Laboratories received Emergency Use Authorization (EUA) for its Abbott ID NOW COVID-19 test which can deliver positive results within five minutes and negative results within 13 minutes. Such strategic initiatives fueled by the pandemic are expected to boost market growth in the near future.
Nucleic Acid Amplification Testing Market Report Highlights
- Polymerase Chain Reaction (PCR) tests held the largest share of 66.68% in 2021 as the testing type allows for the high accuracy and multiplexing capabilities for the detection of a broad range of pathogens
- By application, infectious diseases accounted for the largest share of 46.16% in 2021. The rising prevalence of the infectious disease globally and efficient testing alternatives offered by nucleic acid amplification techniques are driving the segment
- North America held the largest share of 36.96% in 2021, due to the presence of an established healthcare sector and key players such as Abbott Laboratories; Illumina, Inc.; Bio-Rad Laboratories, Inc., and others in the region
- Central and reference laboratories end-use segment dominated the market in 2021 with a market share of 41.80% in 2021 due to the increasing healthcare investments and rising adoption of nucleic acid amplification tests for early disease diagnosis
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.12 List of Abbreviations
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Market Summary
CHAPTER 3 NUCLEIC ACID AMPLIFICATION TESTING MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Trends & Outlook
3.2 Market Segmentation & Scope
3.3 Market Driver Analysis
3.3.1 Increasing Prevalence Of Chronic And Infectious Diseases Is Driving The Market Growth
3.3.2 Rise In The Aging Population Across The Globe Is Expected To Boost The Market Growth
3.3.3 Technological Advancements In Nucleic Acid Amplification Testing Can Increase The Adoption Of The Technique
3.4 Market Restraint Analysis
3.4.1 Stringent Regulatory Framework Can Limit The Market Growth
3.4.2 Lack Of Awareness About New Diagnostics Technologies Can Impede The Markt Growth
3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.6 Porter’s Five Forces Analysis
3.7 COVID-19 Impact Analysis
3.8 Penetration & Growth Prospect Mapping
CHAPTER 4 NUCLEIC ACID AMPLIFICATION TESTING MARKET - SEGMENT ANALYSIS, BY TYPE, 2018 - 2030 (USD MILLION)
4.1 Nucleic Acid Amplification Testing Market: Type Movement Analysis
4.2 Polymerase Chain Reaction (PCR) tests
4.2.1 Polymerase Chain Reaction (Pcr) TestsMarket Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Isothermal Nucleic Acid Amplification Technology (Inaat) Tests
4.3.1 Isothermal Nucleic Acid Amplification Technology (Inaat) Tests Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 Ligase Chain Reaction (Lcr) Tests
4.4.1 Ligase Chain Reaction (Lcr) Tests Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 5 NUCLEIC ACID AMPLIFICATION TESTING MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
5.1 Nucleic Acid Amplification Testing Market: Application Movement Analysis
5.2 Infectious disease testing
5.2.1 Infectious Disease Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.2 Covid-19 Testing
5.2.2.1 Covid-19 Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.3 Mosquito Borne Disease Testing
5.2.3.1 Mosquito Borne Disease Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.4 Influenza Testing
5.2.4.1 Influenza Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.5 Sexually Transmitted Infections Testing
5.2.5.1 Sexually Transmitted Infection Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.6 Hepatitis Testing
5.2.6.1 Hepatitis Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.7 Tuberculosis Testing
5.2.7.1 Tuberculosis testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.8 Others
5.2.8.1 Other Infectious Disease Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Oncology Testing
5.3.1 Oncology Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Genetic & Mitochondrial Disease Testing
5.4.1 Genetic & Mitochondrial Disease Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Others
5.5.1 Other Application Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 NUCLEIC ACID AMPLIFICATION TESTING MARKET - SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
6.1 Nucleic Acid Amplification Testing Market: End-use Movement Analysis
6.2Hospitals
6.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Central And Reference Laboratories
6.3.1 Central And Reference Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Others
6.4.1 Other End-Use Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 NUCLEIC ACID AMPLIFICATION TESTING MARKET - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
7.1 Nucleic Acid Amplification Testing Market: Regional Movement Analysis
7.2 North America
7.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Middle East And Africa
7.6.1 Middle-East And Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 COMPETITIVE ANALYSIS
8.1 Strategy Framework
8.2 Company/Competition Categorization
8.3 Company Profiles
8.3.1 F. HOFFMANN-LA ROCHE LTD
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 BECTON, DICKINSON AND COMPANY
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 DANAHER CORPORATION
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 ABBOTT LABORATORIES
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 ILLUMINA, INC.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 SIEMENS HEALTHINEERS
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 BIOM?RIEUX SA
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 NOVARTIS AG
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 BIO-RAD LABORATORIES, INC.
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 SEEGENE INC.
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.12 List of Abbreviations
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Market Summary
CHAPTER 3 NUCLEIC ACID AMPLIFICATION TESTING MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Trends & Outlook
3.2 Market Segmentation & Scope
3.3 Market Driver Analysis
3.3.1 Increasing Prevalence Of Chronic And Infectious Diseases Is Driving The Market Growth
3.3.2 Rise In The Aging Population Across The Globe Is Expected To Boost The Market Growth
3.3.3 Technological Advancements In Nucleic Acid Amplification Testing Can Increase The Adoption Of The Technique
3.4 Market Restraint Analysis
3.4.1 Stringent Regulatory Framework Can Limit The Market Growth
3.4.2 Lack Of Awareness About New Diagnostics Technologies Can Impede The Markt Growth
3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.6 Porter’s Five Forces Analysis
3.7 COVID-19 Impact Analysis
3.8 Penetration & Growth Prospect Mapping
CHAPTER 4 NUCLEIC ACID AMPLIFICATION TESTING MARKET - SEGMENT ANALYSIS, BY TYPE, 2018 - 2030 (USD MILLION)
4.1 Nucleic Acid Amplification Testing Market: Type Movement Analysis
4.2 Polymerase Chain Reaction (PCR) tests
4.2.1 Polymerase Chain Reaction (Pcr) TestsMarket Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Isothermal Nucleic Acid Amplification Technology (Inaat) Tests
4.3.1 Isothermal Nucleic Acid Amplification Technology (Inaat) Tests Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 Ligase Chain Reaction (Lcr) Tests
4.4.1 Ligase Chain Reaction (Lcr) Tests Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 5 NUCLEIC ACID AMPLIFICATION TESTING MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
5.1 Nucleic Acid Amplification Testing Market: Application Movement Analysis
5.2 Infectious disease testing
5.2.1 Infectious Disease Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.2 Covid-19 Testing
5.2.2.1 Covid-19 Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.3 Mosquito Borne Disease Testing
5.2.3.1 Mosquito Borne Disease Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.4 Influenza Testing
5.2.4.1 Influenza Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.5 Sexually Transmitted Infections Testing
5.2.5.1 Sexually Transmitted Infection Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.6 Hepatitis Testing
5.2.6.1 Hepatitis Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.7 Tuberculosis Testing
5.2.7.1 Tuberculosis testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.8 Others
5.2.8.1 Other Infectious Disease Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Oncology Testing
5.3.1 Oncology Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Genetic & Mitochondrial Disease Testing
5.4.1 Genetic & Mitochondrial Disease Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Others
5.5.1 Other Application Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 NUCLEIC ACID AMPLIFICATION TESTING MARKET - SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
6.1 Nucleic Acid Amplification Testing Market: End-use Movement Analysis
6.2Hospitals
6.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Central And Reference Laboratories
6.3.1 Central And Reference Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Others
6.4.1 Other End-Use Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 NUCLEIC ACID AMPLIFICATION TESTING MARKET - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
7.1 Nucleic Acid Amplification Testing Market: Regional Movement Analysis
7.2 North America
7.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Middle East And Africa
7.6.1 Middle-East And Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 COMPETITIVE ANALYSIS
8.1 Strategy Framework
8.2 Company/Competition Categorization
8.3 Company Profiles
8.3.1 F. HOFFMANN-LA ROCHE LTD
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 BECTON, DICKINSON AND COMPANY
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 DANAHER CORPORATION
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 ABBOTT LABORATORIES
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 ILLUMINA, INC.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 SIEMENS HEALTHINEERS
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 BIOM?RIEUX SA
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 NOVARTIS AG
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 BIO-RAD LABORATORIES, INC.
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 SEEGENE INC.
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 4 Global nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 5 Global nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 6 Global nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
Table 7 North America nucleic acid amplification testing market, by country, 2018 - 2030 (USD Million)
Table 8 North America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 9 North America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 10 North America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 11 U.S. nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 12 U.S. nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 13 U.S. nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 14 Canada nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 15 Canada nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 16 Canada nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 17 Europe nucleic acid amplification testing market, by country, 2018 - 2030 (USD Million)
Table 18 Europe nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 19 Europe nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 20 Europe nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 21 Germany nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 22 Germany nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 23 Germany nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 24 U.K. nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 25 U.K. nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 26 U.K. nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 27 France nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 28 France nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 29 France nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 30 Italy nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 31 Italy nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 32 Italy nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 33 Spain nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 34 Spain nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 35 Spain nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 36 Asia Pacific nucleic acid amplification testing market, by country, 2018 - 2030 (USD Million)
Table 37 Asia Pacific nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 38 Asia Pacific nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 39 Asia Pacific nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 40 China nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 41 China nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 42 China nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 43 Japan nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 44 Japan nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 45 Japan nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 46 India nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 47 India nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 48 India nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 49 South Korea nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 50 South Korea nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 51 South Korea nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 52 Australia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 53 Australia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 54 Australia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 55 Latin America nucleic acid amplification testing market, by country, 2018 - 2030 (USD Million)
Table 56 Latin America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 57 Latin America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 58 Latin America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 59 Brazil nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 60 Brazil nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 61 Brazil nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 62 Mexico nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 63 Mexico nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 64 Mexico nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 65 Middle East & Africa nucleic acid amplification testing market, by country, 2018 - 2030 (USD Million)
Table 66 Middle East & Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 67 Middle East & Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 68 Middle East & Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 69 South Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 70 South Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 71 South Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 72 Saudi Arabia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 73 Saudi Arabia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 74 Saudi Arabia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 75 UAE nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 76 UAE nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 77 UAE nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 4 Global nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 5 Global nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 6 Global nucleic acid amplification testing market, by region, 2018 - 2030 (USD Million)
Table 7 North America nucleic acid amplification testing market, by country, 2018 - 2030 (USD Million)
Table 8 North America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 9 North America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 10 North America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 11 U.S. nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 12 U.S. nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 13 U.S. nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 14 Canada nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 15 Canada nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 16 Canada nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 17 Europe nucleic acid amplification testing market, by country, 2018 - 2030 (USD Million)
Table 18 Europe nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 19 Europe nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 20 Europe nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 21 Germany nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 22 Germany nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 23 Germany nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 24 U.K. nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 25 U.K. nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 26 U.K. nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 27 France nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 28 France nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 29 France nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 30 Italy nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 31 Italy nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 32 Italy nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 33 Spain nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 34 Spain nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 35 Spain nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 36 Asia Pacific nucleic acid amplification testing market, by country, 2018 - 2030 (USD Million)
Table 37 Asia Pacific nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 38 Asia Pacific nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 39 Asia Pacific nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 40 China nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 41 China nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 42 China nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 43 Japan nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 44 Japan nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 45 Japan nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 46 India nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 47 India nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 48 India nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 49 South Korea nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 50 South Korea nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 51 South Korea nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 52 Australia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 53 Australia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 54 Australia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 55 Latin America nucleic acid amplification testing market, by country, 2018 - 2030 (USD Million)
Table 56 Latin America nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 57 Latin America nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 58 Latin America nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 59 Brazil nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 60 Brazil nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 61 Brazil nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 62 Mexico nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 63 Mexico nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 64 Mexico nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 65 Middle East & Africa nucleic acid amplification testing market, by country, 2018 - 2030 (USD Million)
Table 66 Middle East & Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 67 Middle East & Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 68 Middle East & Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 69 South Africa nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 70 South Africa nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 71 South Africa nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 72 Saudi Arabia nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 73 Saudi Arabia nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 74 Saudi Arabia nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
Table 75 UAE nucleic acid amplification testing market, by type, 2018 - 2030 (USD Million)
Table 76 UAE nucleic acid amplification testing market, by application, 2018 - 2030 (USD Million)
Table 77 UAE nucleic acid amplification testing market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Nucleic Acid Amplification Testing, Market Segmentation
Fig. 8 Market Snapshot, 2021
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 15 Global nucleic acid amplification testing market: Type Movement Analysis
Fig. 16 Global nucleic acid amplification testing market for Polymerase Chain Reaction (PCR) tests, 2018 - 2030 (USD Million)
Fig. 17 Global nucleic acid amplification testing market for Isothermal Nucleic Acid Amplification Technology (INAAT) tests, 2018 - 2030 (USD Million)
Fig. 18 Global nucleic acid amplification testing market for Ligase Chain Reaction (LCR) tests, 2018 - 2030 (USD Million)
Fig. 19 Global nucleic acid amplification testing market: Application, Movement Analysis
Fig. 20 Global nucleic acid amplification testing market for infectious disease testing, 2018 - 2030 (USD Million)
Fig. 21 Global nucleic acid amplification testing market for COVID-19 testing, 2018 - 2030 (USD Million)
Fig. 22 Global nucleic acid amplification testing market for mosquito borne disease testing, 2018 - 2030 (USD Million)
Fig. 23 Global nucleic acid amplification testing market for influenza testing, 2018 - 2030 (USD Million)
Fig. 24 Global nucleic acid amplification testing market for sexually transmitted infections testing, 2018 - 2030 (USD Million)
Fig. 25 Global nucleic acid amplification testing market for hepatitis testing, 2018 - 2030 (USD Million)
Fig. 26 Global nucleic acid amplification testing market for tuberculosis testing, 2018 - 2030 (USD Million)
Fig. 27 Global nucleic acid amplification testing market for other infectious disease testing, 2018 - 2030 (USD Million)
Fig. 28 Global nucleic acid amplification testing market for oncology testing, 2018 - 2030 (USD Million)
Fig. 29 Global nucleic acid amplification testing market for genetic & mitochondrial disease testing, 2018 - 2030 (USD Million)
Fig. 30 Global nucleic acid amplification testing market for others, 2018 - 2030 (USD Million)
Fig. 31 Global nucleic acid amplification testing market: End-use, Movement Analysis
Fig. 32 Global nucleic acid amplification testing market for hospitals, 2018 - 2030 (USD Million)
Fig. 33 Global nucleic acid amplification testing market for central and reference laboratories, 2018 - 2030 (USD Million)
Fig. 34 Global nucleic acid amplification testing market for others, 2018 - 2030 (USD Million)
Fig. 35 Regional Marketplace: Key Takeaways
Fig. 36 Regional Outlook, 2021 & 2030
Fig. 37 Global nucleic acid amplification testing market: Region Movement Analysis
Fig. 38 North America nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 39 U.S. nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 40 Canada nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 41 Europe nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 42 Germany nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 43 U.K. nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 44 France nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 45 Italy nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 46 Spain nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 47 Asia Pacific nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 48 Japan nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 49 China nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 50 India nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 51 Australia nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 52 South Korea nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 53 Latin America nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 54 Brazil nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 55 Mexico nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 56 Middle East and Africa nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 57 South Africa nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 58 Saudi Arabia nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 59 UAE nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Nucleic Acid Amplification Testing, Market Segmentation
Fig. 8 Market Snapshot, 2021
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 15 Global nucleic acid amplification testing market: Type Movement Analysis
Fig. 16 Global nucleic acid amplification testing market for Polymerase Chain Reaction (PCR) tests, 2018 - 2030 (USD Million)
Fig. 17 Global nucleic acid amplification testing market for Isothermal Nucleic Acid Amplification Technology (INAAT) tests, 2018 - 2030 (USD Million)
Fig. 18 Global nucleic acid amplification testing market for Ligase Chain Reaction (LCR) tests, 2018 - 2030 (USD Million)
Fig. 19 Global nucleic acid amplification testing market: Application, Movement Analysis
Fig. 20 Global nucleic acid amplification testing market for infectious disease testing, 2018 - 2030 (USD Million)
Fig. 21 Global nucleic acid amplification testing market for COVID-19 testing, 2018 - 2030 (USD Million)
Fig. 22 Global nucleic acid amplification testing market for mosquito borne disease testing, 2018 - 2030 (USD Million)
Fig. 23 Global nucleic acid amplification testing market for influenza testing, 2018 - 2030 (USD Million)
Fig. 24 Global nucleic acid amplification testing market for sexually transmitted infections testing, 2018 - 2030 (USD Million)
Fig. 25 Global nucleic acid amplification testing market for hepatitis testing, 2018 - 2030 (USD Million)
Fig. 26 Global nucleic acid amplification testing market for tuberculosis testing, 2018 - 2030 (USD Million)
Fig. 27 Global nucleic acid amplification testing market for other infectious disease testing, 2018 - 2030 (USD Million)
Fig. 28 Global nucleic acid amplification testing market for oncology testing, 2018 - 2030 (USD Million)
Fig. 29 Global nucleic acid amplification testing market for genetic & mitochondrial disease testing, 2018 - 2030 (USD Million)
Fig. 30 Global nucleic acid amplification testing market for others, 2018 - 2030 (USD Million)
Fig. 31 Global nucleic acid amplification testing market: End-use, Movement Analysis
Fig. 32 Global nucleic acid amplification testing market for hospitals, 2018 - 2030 (USD Million)
Fig. 33 Global nucleic acid amplification testing market for central and reference laboratories, 2018 - 2030 (USD Million)
Fig. 34 Global nucleic acid amplification testing market for others, 2018 - 2030 (USD Million)
Fig. 35 Regional Marketplace: Key Takeaways
Fig. 36 Regional Outlook, 2021 & 2030
Fig. 37 Global nucleic acid amplification testing market: Region Movement Analysis
Fig. 38 North America nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 39 U.S. nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 40 Canada nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 41 Europe nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 42 Germany nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 43 U.K. nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 44 France nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 45 Italy nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 46 Spain nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 47 Asia Pacific nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 48 Japan nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 49 China nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 50 India nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 51 Australia nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 52 South Korea nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 53 Latin America nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 54 Brazil nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 55 Mexico nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 56 Middle East and Africa nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 57 South Africa nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 58 Saudi Arabia nucleic acid amplification testing market, 2018 - 2030 (USD Million)
Fig. 59 UAE nucleic acid amplification testing market, 2018 - 2030 (USD Million)
